Weaker Buy Today ARRY ranks #301 as BUY CANDIDATE #301 Stronger Buy

Array BioPharma Inc. stock forecast

ARRY stock forecast

Friday June 14, 2019 Change 0.58% Price $29.59
Chart period: 2019-03-15 - 2019-06-14




Social Sentiment for ARRY

Today's data is from 7 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
Weighted Sentiment -0.10

Will ARRY stock price go up or down on Mon, 17 Jun 2019?


Array BioPharma Inc. Forecast and Stock Analysis

Technical ARRY stock analysis for Friday June 14, 2019.

Buy candidate since 2019-06-11 Gain 3.14%

Array BioPharma Inc. gained 0.58% in the last trading day ( Friday, 14th Jun 2019 ), rising from $29.42 to $29.59 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During day the stock fluctuated 2.34% from a day low at $29.06 to a day high of $29.74. The price has risen in 8 of the last 10 days and is up by 12% over the past 2 weeks. Volume fell in the last day by -0.08 million shares, and in total, 1.70 million shares bought and sold for approximately $50.27 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the ARRY stock price was $29.81 and low was $20.93.
  • 90 day high was $29.81 and low was $20.72.
  • 52 week high for the Array BioPharma Inc. - $29.81 and low - $12.56.


Array BioPharma Inc. lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $29.81 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 18.21% during the next 3 months and, with 90% probability hold a price between $26.33 and $35.24 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Array BioPharma Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $29.12 and $25.13. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday May 20, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 67 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $26.40 and $25.77.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Array BioPharma Inc. finds support just below today's level at $26.40. If this is broken, then the next support from accumulated volume will be at $25.77 and $25.55.

Support: $26.40 Price: $29.59


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.68 between high and low, or 2.34%. For the last week, the stock has had a daily average volatility of 2.61%.

Our recommended stoploss: $28.22 (-4.62%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 18 days ago.)

2.61 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate Downgraded
Weaker Buy Today ARRY ranks #301 as BUY CANDIDATE #301 Stronger Buy

Will ARRY stock price go up or down on Mon, 17 Jun 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank